Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 80,210	$ 51,367
Accounts receivable, net	29,687	24,639
Restricted cash, current	0	150
Prepaid expenses and other current assets	8,545	6,132
Total current assets	118,442	82,288
Property and equipment, net	8,070	8,920
Operating lease right-of-use assets	17,894	18,805
Restricted cash, non-current	4,475	4,325
Other non-current assets	10,482	4,366
Total assets	159,363	118,704
Current liabilities:
Accounts payable	1,786	2,870
Accrued expenses and other current liabilities	25,664	25,319
Operating lease liabilities, current	5,492	5,416
Total current liabilities	32,942	33,605
Convertible notes	68,336	0
Term loan	114,087	136,431
Common stock warrant liability	23,304	20,835
Derivative liability	29,407	0
Operating lease liabilities, non-current	17,235	18,537
Other non-current liabilities	281	214
Total liabilities	285,592	209,622
Commitments and contingencies (Note 7)
Redeemable convertible preferred stock issuable in series, $0.001 par value; 122,231,454 shares authorized, issued and outstanding as of June 30, 2025 and December 31, 2024; aggregate liquidation value of $951,917 as of June 30, 2025 and December 31, 2024	768,566	768,566
Stockholders’ deficit:
Common stock, $0.001 par value; 210,300,000 shares authorized as of June 30, 2025 and December 31, 2024; 6,389,444 and 6,122,048 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	6	6
Additional paid-in capital	118,416	112,241
Accumulated other comprehensive loss	(717)	(772)
Accumulated deficit	(1,012,500)	(970,959)
Total stockholders’ deficit	(894,795)	(859,484)
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit	$ 159,363	$ 118,704